Vera Therapeutics grants inducement equity awards to five new employees under Nasdaq rule exemption

• Vera Therapeutics granted inducement equity awards to five new employees on Sept. 29, 2026.
• Awards comprise non-qualified stock options for 16,700 shares, exercise price $32.38, tied to the Sept. 29 close.
• Restricted stock units cover 8,350 shares, vesting over four years with 25% each Nov. 20 anniversary.
• Options vest over four years, with 25% after one year, then monthly over 36 months, contingent on continued service.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vera Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610021605PRIMZONEFULLFEED9837613) on October 02, 2026, and is solely responsible for the information contained therein.